Case study highlights clinical implications of PPAR activation by cannabidiol.
Glutamate, A Love Story
From the “Get to Know a Neurotransmitter” series: Glutamate excites!
Real-World CBD Evidence, CBD & Ketamine, and More
New developments in the burgeoning field of cannabinoid research.
Synthetic Cannabinoids: Dangerous for Diabetics?
While smoking cannabis appears to be helpful for diabetics managing weight and insulin levels, synthetic cannabinoids could be dangerous.
Toxic FDA-Approved Food Additives
The Food and Drug Administration bans CBD edibles while routinely promoting dietary poisons.
CBD Does Not Go Better with Coke
Coca-Cola is eyeing CBD as a functional food additive, while the beverage giant promotes sugary drinks for overweight children.
Leafy Greens & Diabetes
β-caryophyllene is a terpene present in cannabis as well as many dark green, leafy vegetables.
Cannabis, Antipsychotics & Liver Health
Cannabis use may protect against steatosis, the abnormal accumulation of lipids in the liver.
Exercise Modulates Endocannabinoid Activity
Chinese scientists describe how the ECS may mediate the numerous cognitive effects of exercise.
Cannabis: Gateway to Herbal Medicine
Compounds in dozens of plants interact with the endocannabinoid system.